Skip to main content
Equibles
SKIN logo

SKIN · SkinHealth Systems Inc. · Metrics

Track SKIN — free

Use SKIN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SKIN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.88 -0.22 (-1.94%) At close · Oct 23
Rebalance outlook locked
Market Cap
$70.80M
Shares
6.51M
Volume · Oct 23 51.05K Avg daily vol (8 sessions) 52.39K

SKIN metrics

64 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$10.88
Market cap
$70.80M

Price action

20 metrics
Price change (1W)
+3.0%
Price change (30D)
-5.9%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Annualized volatility (3M)
—
Beta
—
RSI (14D)
—
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Consumer Defensive
Industry
Household & Personal Products
Shares outstanding
6.51M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.7×
reciprocal yield 138.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 409.7%
P / book
1.3
reciprocal yield 78.5%
FCF yield
29.9%
TTM · current market cap
Buyback yield
—
P / FCF
3.3
reciprocal yield 29.9%
P / operating cash flow
3.2
reciprocal yield 31.0%
Earnings yield
-40.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.4×
reciprocal yield 72.1%
EV / revenue historical average (5Y)
3.3×
reciprocal yield 30.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-05
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
66.4%
Operating margin
-1.5%
Trailing 12 months
Net margin
-9.8%
Gross profit (TTM)
$192.45M
Operating profit (TTM)
−$4.31M
Net income (TTM)
−$28.43M
Trailing 12 months
Diluted EPS (TTM)
$-3.60
FCF margin
7.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$9.58

Growth

11 metrics
Revenue growth YoY
-7.8%
Year over year
Net income growth YoY
-113.5%
Revenue (TTM)
$290.05M
Trailing 12 months
EPS growth YoY
-166.7%
Shares change YoY
-7.6%
Year over year · fewer shares
Revenue CAGR (3Y)
-6.3%
Revenue CAGR (5Y)
+20.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-51.2%
Return on assets
-5.8%
Debt / equity
6.2
Current ratio
1.8
EBITDA (TTM)
—
Free cash flow (TTM)
$21.14M
Quick ratio
1.5
Interest coverage
-0.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$139.13M
Latest balance sheet
Cash & equivalents
$206.07M
Total assets
$486.57M
Total debt
$345.21M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$21.96M
Capital expenditures (TTM)
$817,000
R&D (TTM)
$5.89M
SG&A (TTM)
—
Stock compensation (TTM)
$11.01M
R&D / revenue
2.0%
Stock compensation / revenue
3.8%

Ownership (13F)

9 metrics
13F filers
98
13F filer change QoQ
-19
Institutional ownership
54.3%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
31.1%
Private-fund adviser ownership
29.7%
Active holders' share change QoQ
-13.1%
Holder tenure
9.3
Price vs estimated holder cost
-86.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
6.2%

Short interest

3 metrics
Short interest
5.6%
Latest settlement · 21.8 days to cover
Days to cover
21.8d
Short-squeeze score
72 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1818093 CUSIP 88331L108 13F (30d) 6 filings 6 filers Visit website Investor relations